Literature DB >> 27471127

Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.

Leonid Barkhatov1,2, Åsmund A Fretland3,4,5, Airazat M Kazaryan3,6,7, Bård I Røsok5, Kristoffer W Brudvik5, Anne Waage5, Bjørn A Bjørnbeth5, Mushegh A Sahakyan3,4, Bjørn Edwin3,4,5.   

Abstract

OBJECTIVE: The aim of this study was to validate clinical risk scores in patients underwent laparoscopic resection of colorectal liver metastases (CLM) with 5 years follow-up or more, and assess 5- and 10-year actual survival in this group.
METHODS: A total of 516 laparoscopic liver resections were performed in 406 patients with CLM between February 1998 and September 2015. A follow-up of 5 and 10 years could be assessed in 144 and 29 patients, respectively. The Fong score, pre- and postoperative Basingstoke Predictive Index (BPI), Nordlinger score, and Iwatsuki score were validated.
RESULTS: Five- and ten-year cancer-related actual survival was 54% and 32%, respectively. The Fong score, pre- and postoperative BPI and the Nordlinger score divided patients into risk groups with significant difference in survival between the groups. However, predicted 5-year survival rates were lower than the actual 5-year survival (mean difference in 17%,13%, 20%, and 30%, respectively).
CONCLUSION: The Fong score, pre- and postoperative BPI and the Nordlinger score systems can be used to predict survival for laparoscopically operated patients in the era of multimodal-treatment after adjusting of survival rates. The actual five- and 10-year survival after laparoscopic resection of CLM is similar to results previously published for open liver resection. J. Surg. Oncol. 2016;114:757-763.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  clinical risk scores; colorectal liver metastases; laparoscopic liver resection

Mesh:

Year:  2016        PMID: 27471127     DOI: 10.1002/jso.24391

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Does the laparoscopic approach for liver resections for colorectal liver metastasis truly confer improved survival outcomes?

Authors:  Nita Thiruchelvam; David Cavallucci; Adrian Kah Heng Chiow
Journal:  Hepatobiliary Surg Nutr       Date:  2020-12       Impact factor: 7.293

2.  Laparoscopic Parenchyma-sparing Liver Resection for Colorectal Metastases.

Authors:  Davit L Aghayan; Egidijus Pelanis; Åsmund Avdem Fretland; Airazat M Kazaryan; Mushegh A Sahakyan; Bård I Røsok; Leonid Barkhatov; Bjørn Atle Bjørnbeth; Ole Jakob Elle; Bjørn Edwin
Journal:  Radiol Oncol       Date:  2017-11-01       Impact factor: 2.991

3.  FLOT2 overexpression is associated with the progression and prognosis of human colorectal cancer.

Authors:  Taiyuan Li; Chuanlin Cao; Qiangqiang Xiong; Dongning Liu
Journal:  Oncol Lett       Date:  2019-01-02       Impact factor: 2.967

4.  Laparoscopic liver resection for colorectal liver metastases - short- and long-term outcomes: A systematic review.

Authors:  Emily Taillieu; Celine De Meyere; Frederiek Nuytens; Chris Verslype; Mathieu D'Hondt
Journal:  World J Gastrointest Oncol       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.